Management of Infants with Congenital Adrenal Hyperplasia

Simple item page
dc.contributor.authorDabas, Aashimaen_US
dc.contributor.authorVats, Pallavien_US
dc.contributor.authorSharma, Rajnien_US
dc.contributor.authorSingh, Preetien_US
dc.contributor.authorSeth, Anjuen_US
dc.contributor.authorJain, Vandanaen_US
dc.contributor.authorBatra, Prernaen_US
dc.contributor.authorGupta, Neerjaen_US
dc.contributor.authorKumar, Ravindraen_US
dc.contributor.authorKabra, Madhulikaen_US
dc.contributor.authorKapoor, Seemaen_US
dc.contributor.authorYadav, Sangeetaen_US
dc.date.accessioned2020-04-23T07:45:02Z
dc.date.available2020-04-23T07:45:02Z
dc.date.issued2020-02
dc.description.abstractTreatment of congenital adrenal hyperplasia (CAH) requires lifelong replacement of glucocorticoids with regular follow up to manageassociated morbidities. The current review focuses on follow-up and management of infants diagnosed with classical CAH pertinent toIndian context. Early initiation of oral hydrocortisone in divided doses is recommended after diagnosis in newborn period, infancy andchildhood. Fludrocortisone is recommended for all infants with classical CAH. All infants should be monitored as per protocol fordisease and treatment related complications. The role of prenatal steroids to pregnant women with previous history of CAH affectedinfant for prevention of virilization of female fetus is controversial.en_US
dc.identifier.affiliationsDepartments of Pediatrics, 1Maulana Azad Medical College and Lok Nayak Hospitalen_US
dc.identifier.affiliationsAll India Institute of Medical Sciencesen_US
dc.identifier.affiliationsLady Hardinge Medical College and Kalawati Saran Children’s hospitalen_US
dc.identifier.affiliationsHindu Rao hospitalen_US
dc.identifier.affiliationsUniversity College of MedicalSciences and Guru Teg Bahadur hospital; New Delhi, Indiaen_US
dc.identifier.citationDabas Aashima, Vats Pallavi, Sharma Rajni, Singh Preeti, Seth Anju, Jain Vandana, Batra Prerna, Gupta Neerja, Kumar Ravindra, Kabra Madhulika, Kapoor Seema, Yadav Sangeeta. Management of Infants with Congenital Adrenal Hyperplasia. Indian Pediatrics. 2020 Feb; 57(2): 159-164en_US
dc.identifier.issn0974-7559
dc.identifier.issn0019-6061
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/199480
dc.languageenen_US
dc.publisherIndian Academy of Pediatricsen_US
dc.relation.issuenumber2en_US
dc.relation.volume57en_US
dc.source.urihttps://www.indianpediatrics.net/feb2020/159.pdfen_US
dc.subjectAdrenal crisisen_US
dc.subjectComplicationen_US
dc.subjectGlucocorticoiden_US
dc.subject17OHPen_US
dc.subjectMineralocorticoiden_US
dc.titleManagement of Infants with Congenital Adrenal Hyperplasiaen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ip2020v57n2p159.pdf
Size:
46.26 KB
Format:
Adobe Portable Document Format
Download
Collections
Indian Pediatrics